Zobrazeno 1 - 10
of 129
pro vyhledávání: '"Yuko Tsuchiya"'
Autor:
Christine Guzman, Kurato Mohri, Ryotaro Nakamura, Minato Miyake, Yuko Tsuchiya, Kentaro Tomii, Hiroshi Watanabe
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract The evolutionary transition from diffusion-mediated cell-cell communication to faster, targeted synaptic signaling in animal nervous systems is still unclear. Genome sequencing analyses have revealed a widespread distribution of synapse-rela
Externí odkaz:
https://doaj.org/article/07de6de230e645a288af6fe198e588b6
Autor:
Soichiro Sakoda, Kentaro Tanaka, Yuichiro Koga, Hironori Mikumo, Yuko Tsuchiya‐Kawano, Eiji Harada, Sadafumi Tamiya, Isamu Okamoto
Publikováno v:
Thoracic Cancer, Vol 15, Iss 5, Pp 415-418 (2024)
Abstract Metastatic inflammatory myofibroblastic tumor (IMT) is very rare and detailed reports on diagnosis and treatment are limited. Here, we report a case of metastatic IMT with ALK rearrangement. A 73‐year‐old woman was diagnosed with IMT inv
Externí odkaz:
https://doaj.org/article/83ab994b16d84da982e1f4ab5ed73ce1
Autor:
Kazushige Wakuda, MD, Hiroyuki Yamaguchi, MD, PhD, Hirotsugu Kenmotsu, MD, PhD, Minoru Fukuda, MD, PhD, Kentaro Ito, MD, Yuko Tsuchiya-Kawano, MD, PhD, Kentaro Tanaka, MD, PhD, Taishi Harada, MD, PhD, Yuki Nakatani, MD, Satoru Miura, MD, Toshihide Yokoyama, MD, Tomomi Nakamura, MD, Miiru Izumi, MD, PhD, Atsushi Nakamura, MD, PhD, Satoshi Ikeda, MD, PhD, Koichi Takayama, MD, PhD, Kenichi Yoshimura, PhD, Kazuhiko Nakagawa, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Kenji Sugio, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 12, Pp 100587- (2023)
Introduction: Osimertinib may be effective in treating central nervous system (CNS) metastasis, but its efficacy in treating radiation therapy (RT)-naive metastasis is unclear. The OCEAN study assessed the efficacy of osimertinib against RT-naive CNS
Externí odkaz:
https://doaj.org/article/2430d3ab5e8943f5b2079f35a13f2fad
Autor:
Shinya Uematsu, Satoru Kitazono, Hisashi Tanaka, Ryota Saito, Yosuke Kawashima, Fumiyoshi Ohyanagi, Takehiro Tozuka, Tsugitomi Ryosuke, Toshio Sakatani, Atsushi Horiike, Takahiro Yoshizawa, Masafumi Saiki, Yuichi Tambo, Junji Koyama, Masaki Kanazu, Keita Kudo, Yuko Tsuchiya‐Kawano, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 14, Iss 2, Pp 168-176 (2023)
Abstract Background The therapeutic efficacy of cytotoxic anticancer drugs has been reported to be enhanced after immune checkpoint inhibitors (ICI) in non–small cell lung cancer; however, it is unclear whether the same is applicable for small cell
Externí odkaz:
https://doaj.org/article/8194827c78724e359bab2959b6fa2bc1
Autor:
Kazuki Takada, Mototsugu Shimokawa, Shinkichi Takamori, Shinichiro Shimamatsu, Fumihiko Hirai, Tetsuzo Tagawa, Tatsuro Okamoto, Motoharu Hamatake, Yuko Tsuchiya-Kawano, Kohei Otsubo, Koji Inoue, Yasuto Yoneshima, Kentaro Tanaka, Isamu Okamoto, Yoichi Nakanishi, Masaki Mori
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Many studies have recently reported the association of concomitant medications with the response and survival in patients with non-small-cell lung cancer (NSCLC) treated with cancer immunotherapy. However, the clinical impact of s
Externí odkaz:
https://doaj.org/article/7ffb67434519442782c281e291c67c5b
Autor:
Hisashi Tanaka, Hiroaki Sakamoto, Takahiro Akita, Fumiyoshi Ohyanagi, Yosuke Kawashima, Yuichi Tambo, Azusa Tanimoto, Atsushi Horiike, Eisaku Miyauchi, Yuko Tsuchiya‐Kawano, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 13, Iss 10, Pp 1471-1478 (2022)
Abstract Background Dacomitinib is the second‐generation epidermal growth factor receptor (EGFR)‐tyrosine kinase inhibitor (TKI) for mutant non–small cell lung cancer (NSCLC). EGFR‐TKIs are often re‐administered in Japan after the disease p
Externí odkaz:
https://doaj.org/article/5e5f715847fd4a66aa35dd6d0e976bda
Autor:
Norihiro Kobayashi, Sokichi Takagi, Teruaki Kinoshita, Osamu Sakata, Fumi Nakano, Naoto Watanabe, Azumi Nomura, Nobuyuki Kawai, Toshiya Hiraiwa, Manabu Okumura, Koji Furukawa, Tomohiro Kasuya, Noritomo Iwama, Jun Yonekubo, Reika Takahara, Seiya Tanaka, Yuko Tsuchiya, Yoshiaki Ikarashi
Publikováno v:
Journal of Water and Environment Technology, Vol 20, Iss 6, Pp 219-237 (2022)
The environmental presence and drinking water contamination of per- and polyfluoroalkyl substances (PFAS) have been reported since the early 2000s. This study seeks to develop a liquid chromatography/tandem mass spectrometry analytical method for the
Externí odkaz:
https://doaj.org/article/4e756c87c2504010976b3cb8b49cc713
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Regulator binding and mutations alter protein dynamics. The transmission of the signal of these alterations to distant sites through protein motion results in changes in protein expression and cell function. The detection of residues involve
Externí odkaz:
https://doaj.org/article/932d74c13585440eb9ce44561746141e
Autor:
Toshifumi Ninomiya, Kohei Otsubo, Teppei Hoshino, Mototsugu Shimokawa, Megumi Nakazawa, Yoriko Sato, Hironori Mikumo, Satoru Kawakami, Shun Mizusaki, Yusuke Mori, Hidenobu Arimura, Yuko Tsuchiya-Kawano, Koji Inoue, Yujiro Uchida, Yoichi Nakanishi
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Although the risk factors for coronavirus disease 2019 (COVID-19) mortality have been identified, there is limited information about the risk factors for disease progression after hospitalization among Japanese patients with COVID
Externí odkaz:
https://doaj.org/article/883fabbfbceb4c97abebbd2341c4f1a8
Publikováno v:
EBioMedicine, Vol 9, Iss C, Pp 87-96 (2016)
The innate immune protein Stimulator of interferon genes (STING) promotes the induction of interferon beta (IFN-β) production via the phosphorylation of its C-terminal tail (CTT) by TANK-binding kinase 1 (TBK1). Potent ligands of STING are, therefor
Externí odkaz:
https://doaj.org/article/d8380d829043433bb61eba1b0b813085